heart disease
Novo Nordisk unveils new semaglutide data on obesity and heart disease at ECO 2025
May 12, 2025Research and Development Cardiology, Novo Nordisk, Obesity, Ozempic, cardiometabolic conditions, heart disease, obesity, semaglutide
Danish biopharma, Novo Nordisk, has announced that it will present new data on metabolic and cardiovascular health at the upcoming …
Insider Interview: Reducing the risk of adverse cardiovascular events
February 3, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma
Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
AstraZeneca to discontinue trial for heart disease drug Epanova
January 13, 2020Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides
AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …
FDA approves alternative approach for Abbot HeartMate 3 heart pump
January 8, 2020Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease
The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …
AstraZeneca and Novoheart team up to develop human ‘heart-in-a-jar’
November 27, 2019Research and Development Heart in a Jar, Novoheart, heart disease
AstraZeneca and Novoheart are collaborating on developing a functioning miniature human heart model of heart failure, a first of its …
Heart disease deaths increase for first time in 50 years
May 13, 2019Sales and Marketing BHF, UK, cardiovascular, health, heart disease, obesity
Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years. …
Galectin-3: The protein paving new treatment avenues
November 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma
Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …
“Triple pill” blood pressure combo proves more effective, safe than standard care
August 16, 2018Research and Development blood pressure, heart attack, heart disease, pharma, triple pill
A “triple pill” combining three established and effective drugs at low dosage levels could prove much more effective in treating …
EMA issues global recall of heart drugs over cancer risk contamination
July 10, 2018Manufacturing and Production EMA, Europe, heart disease, pharma, valsartan
Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …
New AI system for lung cancer and heart disease could save NHS billions
January 4, 2018Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma
A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …
Novartis targets specific patient population with strong Ilaris Phase 3 data
November 14, 2017Manufacturing and Production, Research and Development Ilaris, Novartis, cardiovascular, heart attack, heart disease, pharma
Novartis has presented new Phase 3 data on its cardiovascular drug Ilaris (canakinumab) which demonstrate particular efficacy in a specific …
MSD scores trial success in reducing cardiovascular risk
August 29, 2017Manufacturing and Production, Research and Development MSD, heart attack, heart disease, life sciences, pharma, pharmaceutical
New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …
Where will the next cardiovascular breakthrough come from?
August 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing British Heart Foundation, cardiovascular disease, heart, heart disease, pharma, pharmaceutical
British Heart Foundation’s Jennifer Mitchell, Research Communications Officer, explains the work they are doing to find the next breakthrough treatment …
Mending broken hearts with an injectable patch
August 16, 2017Research and Development biotech, cardiovascular, drugs, heart disease, pharma, pharmaceutical
A team of researchers from the University of Toronto have confronted a problem that had previously had no solution – …
Battling misinformation on the world’s biggest killer
August 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cardiovascular disease, cholesterol, healthcare, heart disease, heart failure, medicine, pharma, pharmaceutical
Simon Williams, Head of Communications and Policy at Heart UK, discusses the threat posed by cholesterol in the development of …
